NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
03/06/2025
Back to search
Official data from USPTO
AMERICA'S BIOPHARMACEUTICAL COMPANIES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
AMERICA'S BIOPHARMACEUTICAL COMPANIES
ST13
US500000087346947Class
9, 16, 35, 41, 42
Filing
87346947
Registration
5377164
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
28
Latest update
03/06/2025
Classification
Registered
Trademark type
Word
Nice classes
9, 16, 35, 41, 42
Filing date
02/23/2017
Registration date
01/09/2018
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/06/2025
Last transaction
03/06/2025
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
01/01/2017
First use in commerce
01/01/2017
Drawing code
4
Owner type
03
Owner location
Washington, DC
Examiner
AWRICH, ELLEN
Current location
Historical data usage
Holders and representatives
Holders
P. A. (pessoa física)
Representatives
B. Brett Heavner Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Technical classification
Nice Classes
Class 9Class 16Class 35Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Electronic downloadable publications in the nature of fact sheetsreportsinfographics regarding biopharmaceuticals and the biopharmaceutical industry
Class 16
Publications in the nature of fact sheetsreportsinfographics regarding biopharmaceuticals and the biopharmaceutical industry
Class 35
Association servicespromoting the interests of research-based prescription drug manufacturers
Class 41
Providing a website featuring non-downloadable publications in the nature of testimonialsinfographicsfact sheetsreportsarticlesvideos regarding biopharmaceuticals and the biopharmaceutical industry
Class 42
Providing online information regarding medical and scientific research in the field of biopharmaceuticals; providing online information on biopharmaceutical research; providing online information in the field of biopharmaceuticals and biopharmaceutical industry regarding biopharmaceutical safety in the nature of biopharmaceutical testing
Publications
History of USPTO decisions and trademark events.
28 publications found
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
03/06/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/06/2025
ES8R
TEAS SECTION 8 RECEIVED
07/09/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/07/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/07/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/07/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03/07/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
03/07/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/09/2023
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
01/09/2018
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/07/2017
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
12/01/2017
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
11/30/2017
IUAA
USE AMENDMENT ACCEPTED
11/30/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/29/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/29/2017
ALIE
ASSIGNED TO LIE
11/28/2017
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
11/15/2017
IUAF
USE AMENDMENT FILED
11/15/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/14/2017
EAAU
TEAS AMENDMENT OF USE RECEIVED
11/14/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/23/2017
GNRT
NON-FINAL ACTION E-MAILED
05/23/2017
CNRT
NON-FINAL ACTION WRITTEN
05/23/2017
DOCK
ASSIGNED TO EXAMINER
05/18/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/02/2017
NWAP
NEW APPLICATION ENTERED
02/27/2017
Continuous trademark protection
Get notified about every new filing that threatens AMERICA'S BIOPHARMACEUTICAL COMPANIES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.